Literature DB >> 15233547

Can GH induce chromosome breaks or microsatellite instability in GH-deficient children?

C Olivieri1, C Danesino, S Scappaticci, M Bozzola.   

Abstract

The role of GH in carcinogenesis is unclear. We studied the effect of recombinant human GH (rhGH) in vitro on chromosomal and genomic instability. Thirteen children, aged 9.57 +/- 1.08 yr (mean +/- SEM), with complete (no.=5) or partial (no.=8) GH deficiency were evaluated before and during GH treatment. We examined the incidence of chromosome and chromatid breaks, and microsatellite instability after in vitro addition of two different doses of rhGH to peripheral blood lymphocytes obtained from the patients. No differences were observed between the samples of GH-deficient children before and after GH therapy as regards the percentage of chromosome and chromatids breaks, and in microsatellite instability. Our data show that in vitro addition of rhGH does not induce chromosomal and/or genomic instability in cultured lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15233547     DOI: 10.1007/BF03351053

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  16 in total

Review 1.  Clinical perspective: acromegaly and cancer: a problem.

Authors:  P J Jenkins; M Besser
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

2.  Risk of leukemia in children treated with human growth hormone: review and reanalysis.

Authors:  D B Allen; A C Rundle; D A Graves; S L Blethen
Journal:  J Pediatr       Date:  1997-07       Impact factor: 4.406

Review 3.  Testing tumors for microsatellite instability.

Authors:  A de la Chapelle
Journal:  Eur J Hum Genet       Date:  1999 May-Jun       Impact factor: 4.246

4.  A study of chromosomal aberrations and chromosomal fragility after recombinant growth hormone treatment.

Authors:  A H Slyper; J D Shadley; P van Tuinen; S M Richton; R G Hoffmann; D T Wyatt
Journal:  Pediatr Res       Date:  2000-05       Impact factor: 3.756

Review 5.  Growth hormone therapy and malignancy.

Authors:  S M Shalet; B M Brennan; R E Reddingius
Journal:  Horm Res       Date:  1997

6.  In vitro effects of growth hormone (GH) and insulin-like growth factor I and II (IGF-I and -II) on chromosome fragility and p53 protein expression in human lymphocytes.

Authors:  S Cianfarani; B Tedeschi; D Germani; S P Prete; P Rossi; P Vernole; D Caporossi; B Boscherini
Journal:  Eur J Clin Invest       Date:  1998-01       Impact factor: 4.686

7.  Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society.

Authors: 
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

8.  Normal mutation frequencies of somatic cells in patients receiving growth hormone therapy.

Authors:  Y W Lin; M Kubota; Y Wakazono; H Hirota; A Okuda; R Bessho; I Usami; A Kataoka; C Yamanaka; Y Akiyama; K Furusho
Journal:  Mutat Res       Date:  1996-01-02       Impact factor: 2.433

9.  The effect of growth hormone and IGF-I on clonogenic growth of hematopoietic cells in leukemic patients during active disease and during remission--a preliminary report.

Authors:  Z Zadik; Z Estrov; Y Karov; T Hahn; Y Barak
Journal:  J Pediatr Endocrinol       Date:  1993 Jan-Mar

10.  Possible effects of growth hormone on development of acute lymphoblastic leukaemia.

Authors:  P C Rogers; D Komp; A Rogol; H Sabio
Journal:  Lancet       Date:  1977-08-27       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.